Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Bioxcel Therapeutics (BTAI – Research Report), Avidity Biosciences (RNA – Research Report) and Sensei Biotherapeutics (SNSE – Research Report).
Bioxcel Therapeutics (BTAI)
In a report released today, Graig Suvannavejh from Mizuho Securities maintained a Buy rating on Bioxcel Therapeutics, with a price target of $19.00. The company’s shares closed last Tuesday at $15.36.
According to TipRanks.com, Suvannavejh is a 2-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Bioxcel Therapeutics with a $48.80 average price target, a 200.3% upside from current levels. In a report released yesterday, Guggenheim also maintained a Buy rating on the stock with a $28.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Avidity Biosciences (RNA)
In a report released today, Joseph Stringer from Needham reiterated a Buy rating on Avidity Biosciences, with a price target of $50.00. The company’s shares closed last Tuesday at $19.32.
According to TipRanks.com, Stringer is a 3-star analyst with an average return of
Currently, the analyst consensus on Avidity Biosciences is a Strong Buy with an average price target of $35.00, representing an 82.2% upside. In a report released yesterday, Chardan Capital also reiterated a Buy rating on the stock with a $29.00 price target.
Sensei Biotherapeutics (SNSE)
Berenberg Bank analyst Zhiqiang Shu maintained a Hold rating on Sensei Biotherapeutics today and set a price target of $6.00. The company’s shares closed last Tuesday at $1.94, close to its 52-week low of $1.45.
According to TipRanks.com, Shu ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
Sensei Biotherapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $5.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on BTAI:
- Analysts Have Conflicting Sentiments on These Technology Companies: Twitter (TWTR), Everbridge (EVBG) and Cleanspark (CLSK)
- Spin Master Expands Digital Games Ecosystem with Acquisition of Nørdlight
- Centerra Gold Announces Quarterly Dividend of C$0.07 per common share
- AbCellera Biologics (ABCL) Receives a Buy from Berenberg Bank
- H.C. Wainwright Sticks to Their Buy Rating for Endeavour Silver (EXK)
